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and VP significantly differed between centres. In patients 
younger than 75 years, synucleinopathies, and pure forms of 
AD, VP, and AGD were more frequent in men. Above 75 years 
of age, more women had pure AD and pure AGD.  Conclu-
sions: The most obvious neuropathological alteration 
should not terminate the diagnostic procedure since copa-
thology is likely to be found. Neuropathological interpreta-
tion of AGD and VP has not been sufficiently established in 
a consensus. Pure forms of synucleinopathies are unlikely 
sole substrates for dementia.  Copyright © 2008 S. Karger AG, Basel 
 Introduction 
 Dementia is a clinical syndrome resulting from het-
erogeneous diseases of the brain. The most common dis-
orders comprise neurodegenerative diseases. These are 
characterized by selective neuronal loss and are accom-
panied by intra-, or extracellular deposition of conforma-
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 Abstract 
 Background: Dementia results from heterogeneous diseas-
es of the brain. Mixed disease forms are increasingly recog-
nized.  Methods: We performed a survey within brain banks 
of BrainNet Europe to estimate the proportion of mixed dis-
ease forms underlying dementia and age- and gender-spe-
cific influences.  Results: Data collected in 9 centres from 
3,303 individuals were analysed. The proportion of patients 
with mixed diagnoses among all cases with Alzheimer dis-
ease (AD), vascular pathology (VP), argyrophilic grain de-
mentia (AGD), and synucleinopathies, such as Lewy body 
 dementia (LBD), Parkinson disease (PD) and synuclein pa-
thology only in the amygdala, was 53.3%. Mixed pathology 
was more frequently reported with LBD, PD, AGD, and VP 
than with AD. The percentage of mixed diagnoses for AGD 
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tionally altered proteins  [1] . Neuropathological classi-
fication depends on the evaluation of the anatomical 
 dis tribution of neuronal loss and cellular/subcellular 
 distribution of specific aggregated proteins  [2] . Consider-
able overlap in the accumulation of different proteins 
questions whether the mere detection of a particular ag-
gregated protein is really a substrate for dementia. In ad-
dition to neurodegenerative diseases, the presence and 
role of vascular pathology is also variably interpreted  [3] . 
These observations underpin the need for detailed neu-
ropathological evaluation and efforts to use common cri-
teria. Multicentre autopsy series may increase the sample 
size and may provide more exact information regarding 
the frequency of pure and mixed forms of disorders, and 
furthermore give estimations of age- and gender-specific 
influences.
 BrainNet Europe is a consortium of brain banks in 
mainland Europe and the UK, which commenced activi-
ties in 2001, expanding to the present grouping in 2004 
(http://www.brainnet-europe.org/). In addition to pro-
moting brain banking as a research resource for Euro-
pean neuroscience through the provision of high-quality 
human brain tissue samples, the major aims of BrainNet 
Europe include the development of gold standards for tis-
sue handling and tissue quality control to best practice 
guidelines for brain banking.
 In the present study, we performed a survey within 
brain banks of BrainNet Europe to estimate the propor-
tion of mixed and pure disease forms underlying demen-
tia syndromes and to estimate age- and gender-specific 
relative frequencies, and finally to compare neuropatho-
logical evaluations of mixed and pure disease forms. Our 
aim was to point out the importance of recognizing co-
occurrence of various pathologies for the sake of clinico-
pathological correlations and therapeutic measures.
 Materials and Methods 
 Collection of Data 
 The following data were requested from the participating cen-
tres: list of neuropathological diagnoses, gender, and age of pa-
tients who died due to a clinically documented dementing disor-
der evaluated during the last 3–5 years using immunohistochem-
ical methods and current diagnostic neuropathological criteria 
(for a detailed list see: http://www.brainnet-europe.org/en/refer-
ences-for-neuropathological-diagnoses.php). Types of case refer-
ral include brain bank donations (n = 6 centres), community hos-
pitals (n = 6), or Creutzfeldt-Jakob disease (CJD) surveillance sys-
tems (n = 3) ( table 1 ). For the evaluation of the frequency of mixed 
pathologies and the effect of gender and age, we used the follow-
ing diagnoses with relevant numbers of cases: Alzheimer disease 
(AD), vascular pathology (VP), argyrophilic grain dementia 
(AGD), CJD, Parkinson disease (PD), Lewy body dementia (LBD), 
neurofibrillary tangle predominant form of dementia (TOD), 
progressive supranuclear palsy (PSP), corticobasal degeneration 
(CBD), and frontotemporal lobar degeneration with ubiquitin-
only-immunoreactive neuronal inclusions (FTLD-U) or associ-
ated with motor neuron disease (FTLD-MND). In addition, all 
cases with any Lewy body pathology (e.g. LBD, PD, and cases with 
synuclein pathology only in the amygdala) were pooled in one 
group as synucleinopathies.
 Statistical Analysis 
 The   2 test was used to compare the proportion of mixed and 
pure diagnoses in different centres, age and gender groups. The 
factorial ANOVA test was used to evaluate differences in age at 
death in different gender groups and diagnostic groups (pure or 
mixed).
Table 1. Summary of collected data 
Center
1 2 3 4 5 6 7 8 9 all
Country Spain Italy Hungary Sweden Finland UK Germany France Austria –
Case referral CH CJS CH, CJS BBD CH,  BBD BBD CH,  BBD CH, BBD, CJS CH, CJS –
Mean age, years 72.16 68.24 75.73 79.19 77.83 76.15 73.53 NA 71.92 74.11
Women 74.43 69.66 78.15 79.71 80.2 78.9 75.28 NA 73.32 76.451
Men 70.82 66.82 71.94 78.55 74.68 73.41 72.35 NA 70.5 71.821
Number of cases included in this study
Total 798 206 235 134 268 250 63 1,196 153 3,303
Women 273 103 143 72 153 124 25 697 77 1,667
Men 525 103 92 62 115 126 38 499 76 1,636
BBD = Brain bank donations; CH = community hospitals; CJS = CJD surveillance systems.
1 Calculated from 2,107 cases.
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 Results 
 Data collected in 9 centres from 3,303 individuals 
(1,667 women and 1,636 men) were analysed (summa-
rized in  table 1 ). For the calculation of the effect of age, 
we used 2,107 cases. The age of individuals ranged be-
tween 18 and 99 years, with a mean age ( 8 standard de-
viation) of 74.14  8 12.07 years for all, 76.45  8 12.29 years 
for women, and 71.82  8 11.4 years for men. The number 
of neuropathological diagnoses, including combined 
ones, in clinically documented dementia cases was 88. 
The number of combined diagnoses was 54 (61.36%) 
( fig. 1 ). In the current paper, we focused on diagnoses 
with relevant numbers of cases (i.e. 1,138 cases with AD, 
1,011 with CJD, 341 with VP, 207 with LBD, 25 with PD, 
a sum of 275 cases with the diagnosis of synucleinopa-
thies, 90 with AGD, 42 with TOD, 36 with PSP, 32 with 
FTLD-U/MND, and 14 with CBD).
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Cerebral amyloid angiopathy
CADASIL
CBD
CJD
LBD
DLDH
Encephalitis
Fahr
Fatal familial insomnia
FTLD with MAPT mutation
FTLD-MND
Huntington disease
Hippocampus sclerosis
Metabolic encephalopathy
Multiple system atrophy
Unclassifiable tauopathy
Paraneoplastic enceophalopathy
PD
Pick disease
Progressive supranuclear palsy
Refsum disease
Spinocerebellar ataxia
Neurofibrillary tangle dementia
CNS tumour
VP
NIFID
FTLD-U
Dementia pugilistica
Alcoholic encephalopathy
 Fig. 1. Neuropathological diagnoses used 
in our cohort. Diagnoses which also ap-
pear in single (‘pure’) forms are listed in 
the column on the left, while combined di-
agnoses are listed in the horizontal row on 
top. The black boxes indicate which pure 
diagnoses may also be present in a com-
bined form. CADASIL = Cerebral autoso-
mal dominant arteriopathy with subcorti-
cal infarcts and leukoencephalopathy; 
DLDH = dementia lacking distinctive his-
topathology; NIFID = neuronal interme-
diate filament inclusion disease; CNS = 
central nervous system. 
 Kovacs et al. Dement Geriatr Cogn Disord 2008;26:343–350346
 Frequency of Mixed and Pure Diagnoses 
 The proportion of patients with mixed diagnoses in the 
group of cases with AD, VP, AGD, and synucleinopathies 
was 53.3%. In cases where combined diagnoses were indi-
cated, AD was found in 89.6% (p  ! 0.01), VP in 52.6%, 
synucleinopathies in 50%, and AGD in 11.4%. The percent-
age of mixed diagnoses for the group of patients with AD, 
VP, LBD, PD, synucleinopathies, AGD, CJD, and FTLD-
U/MND varied between centres ( fig. 2 ); this was signifi-
cant for AGD and VP. Mixed pathology was significantly 
more frequently reported with PD (92%), LBD (61%), AGD 
(67%), and VP (65%) than with AD (43%), while in PSP 
(22%), CBD (21%), and in particular in FTLD-U (9%) and 
CJD (2%) mixed pathology was significantly less frequent-
ly documented as compared to AD, LBD, PD, and VP.
 Influence of Age and Gender 
 We observed significant (p  ! 0.05) differences in age 
at death and distribution of diagnoses: while FTLD-U/
MND and CJD were more frequent in younger patients 
below 75 years, AD, AGD and combined diagnoses were 
more frequent in elderly patients ( fig. 3 a).
 In the total cohort, LBD (also combined with AD) and 
any type of synucleinopathy were more frequent in men. 
In women, only AD with VP was significantly more fre-
quent ( fig. 3 b). In younger patients ( ! 75 years), the detec-
tion of some kind of synucleinopathy as a pure or com-
bined diagnosis was significantly more frequent in men. 
In addition, AD, VP, TOD, and AGD were more frequent 
in men ( fig. 3 c). However, among the patients above 75 
years of age, more women were found with pure AD, pure 
AGD, mixed VP and AD combined with VP ( fig. 3 d). 
More detailed age grouping indicated a female predomi-
nance among patients with TOD aged above 81 years ( ta-
ble 2 ).
 Discussion 
 In this study, we summarized the results of a survey 
within neuropathological centres of BrainNet Europe. 
The following implications may be emphasized: (1) the 
first and most obvious neuropathological alteration 
should not terminate the diagnostic procedure since co-
pathology is likely to be found; (2) the frequency of AGD 
and VP as a combined diagnosis is significantly different 
between brain banks; (3) morphological evidence of a 
Lewy body type of synucleinopathy, including LBD and 
in particular PD, is unlikely the sole neuropathological 
substrate for dementia; (4) neuroscientists using tissue 
from brain banks should be aware of the high probability 
of mixed alterations, in particular in brains of individuals 
above age 75, thus exclusive disease-specific results should 
be interpreted with caution; (5) influence of gender may 
be considered in AD, synucleinopathies, AGD, or TOD.
 Our study shows that   -synuclein and/or vascular pa-
thology frequently accompanies different disorders. Af-
ter the widespread recognition of LBD as a disease entity, 
several autopsy surveys demonstrated a frequency of 
LBD of 20%  [4–11] . Due to bias in the recruitment of sub-
jects to the brain banks involved in this survey, the cur-
rent study has limitations from an epidemiological view-
point; it is not representative, and cannot give reliable es-
timations of the relative frequencies of brain disorders. 
However, it shows that mixed pathology is common and 
thus is in line with recent studies emphasizing the role of 
mixed brain pathologies accounting for most dementia 
cases in community-dwelling older persons  [12] , as well 
as supports the findings of other population-based and 
consecutive autopsy series  [13–15] .
 Interestingly, combined diagnosis was rarely reported 
in CJD or FTLD-U/MND cases. In patients with CJD, 
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 Fig. 2. Boxplot representation of the proportions of mixed forms 
of AD, AGD, CJD, LBD, FTLD (FTLD-U and FTLD-MND), PD, 
any type of synucleinopathy cases (SYN: this includes pooling of 
LBD, PD and cases with synuclein pathology only in the amyg-
dala), and VP. 
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detailed neuropathological examination is usually termi-
nated after the detection of spongiform change and de-
position of the disease-associated prion protein in brain 
tissue, which may hinder the exact evaluation of copath-
ology. In addition, age at onset is generally lower (around 
10 years) compared to the aforementioned diseases. Pre-
viously some cases of FTLD-U/MND may have been 
overlooked when showing prominent tau or   -synuclein 
pathology due to the more difficult interpretation of 
ubiquitin-immunoreactive structures. Recent criteria 
and the introduction of TDP-43 immunostaining may 
help give exact frequencies of copathology  [16] . Indeed, 
overlap with AD or Lewy body pathologies is already not-
ed  [17, 18] .
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 Fig. 3. Age- and gender-specific proportions of pure and mixed diagnoses. Asterisks on the right side of column 
bars indicate significant difference (p  ! 0.05). Synucleinopathy: LBD, PD, and cases with synuclein pathology 
only in the amygdala pooled in one group. F = Female; M = male. 
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 Our results reflect a lack of neuropathological diag-
nostic criteria for AGD and VP, while such criteria are 
more widely accepted and used for AD, LBD and PD. 
AGD is a sporadic 4R tauopathy that is considered in the 
differential diagnosis of late-onset dementias and some 
features may be observed associated with mutations in 
the  tau gene  [19–21] . The detection of argyrophilic grains 
is not uncommon in aged human brains and AGD ac-
counts for around 5% of dementias (see recent review of 
Ferrer et al.  [22] ). Whether the presence of argyrophilic 
grains per se represents a distinct disease process causing 
dementia or whether it lowers the threshold for dementia 
is a matter of debate  [23] . In our cohort, AGD also appears 
as a pure diagnosis. Thus the constellation of main neu-
ropathological abnormalities including oligodendroglial 
coiled bodies and tau-positive pretangles in limbic pro-
jection neurons, in addition to argyrophilic grains  [19, 
22] , may be interpreted as a morphological entity. Since 
the appearance of argyrophilic grains is associated with 
ageing  [24] that increases the frequency of comorbidity, 
pure forms of AGD may be rarely detected in individuals 
with dementia. Copathology is underestimated in par-
ticular in AD cases with neuropil threads in the same 
regions where grains are detected. A more exact evalua-
tion may be obtained by using anti-4R tau immunohisto-
chemistry  [25] . Our results are in line with the variability 
of reported frequency of VP in autopsy series  [4–11] , as 
well as with a recent survey performed amongst neuro-
pathologists about VP  [3] pointing out the lack of detailed 
guidelines indicating what should be looked for at au-
topsy in cases of suspected vascular cognitive impair-
ment. With regard to VP, the lack of quantification of the 
various lesions, as well as an account of their location, is 
a limitation of this study in terms of information on po-
tential vascular correlates of dementia.
 Earlier studies noted that cerebrovascular disease and 
Alzheimer-related pathology frequently occur in subjects 
with PD showing cognitive decline  [26, 27] . Our results 
support the notion that pure forms of synucleinopathies 
are unlikely to be the sole cause of dementing disorder. 
This is exemplified by the amygdala-synuclein variant of 
AD  [28] . PD with dementia more likely shows copathol-
Table 2. List of diagnoses in age and gender groups
Diagnosis Age group
^60 61–70 71–80 681
male female male female male female male female
AD 20 17 57 19 79 92 69 153
AD + VP 0 0 4 2 19 23 17 47
AD + LBD 2 1 12 2 19 13 17 12
AD + synucleinopathy1 0 0 1 1 8 7 4 14
AD + AGD 0 0 0 0 0 0 4 5
AD + other 2 2 8 3 25 16 12 15
LBD 2 1 12 0 24 7 8 14
LBD + VP 0 0 1 0 2 1 1 5
LBD + AGD 0 0 0 0 0 0 1 3
LBD + other 0 0 1 1 2 1 1 1
AGD 0 0 2 0 2 2 6 16
AGD + VP 0 0 0 0 0 0 7 6
AGD + other 0 0 0 0 0 0 2 0
VP 3 1 15 2 15 17 11 17
VP + other 1 1 2 2 8 3 4 5
FTLD-U/MND 9 7 8 2 7 8 0 0
FTLD-U + other 0 1 0 0 0 0 0 0
TOD 1 1 8 3 11 4 0 11
Other 82 54 88 73 82 72 31 57
Sum 125 87 224 113 308 269 200 386
Italic numbers indicate that p < 0.05 (2 statistics). 
1 Unclassified Lewy body synucleinopathy (e.g. in the amygdala). 
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ogy as compared to LBD. A recent study revealed severer 
Alzheimer-related pathology in PD with dementia than 
in LBD  [27] . The clinical relevance of   -synuclein pathol-
ogy in relation to dementia is debated, although some 
studies indicate a causative role  [29–31] . It is of note that 
a recent study based on neuropathological findings also 
emphasized that abundant   -synuclein pathology in cor-
tical and subcortical regions may be detected in many 
subjects without notable signs of dementia  [32, 33] .
 Earlier observations indicated that women are at high-
er risk of developing AD than men  [4, 34] . Our neuropa-
thology-based results in a large series indicate that this 
influence of gender depends on the age group, and is gen-
erally true only for patients above 75 years. Our study 
supports the notion of a male predominance among pa-
tients with LBD  [4] , and we emphasize this in younger age 
groups. We point out that TOD is more frequent in young-
er men, whereas in elderly women the frequency is re-
versed, and that AGD also shows female predominance. 
While these observations could suggest a gender differ-
ence in the pathogenesis of neuronal tau pathology, it 
may also be explained by the increased mortality of men 
 [35] .
 In summary, our survey supports the notion of a high 
frequency of combined pathologies as a morphological 
substrate for dementia and urges the establishment of 
commonly used neuropathological criteria for AGD and 
VP. Knowledge of gender- and age-specific differences 
may serve as a rationale for patient selection in therapeu-
tic trials.
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